Thu, April 2, 2020

David Lebovitz Maintained (ASND) at Buy with Decreased Target to $180 on, Apr 2nd, 2020

David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $181 to $180 on, Apr 2nd, 2020.

David has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Leland Gershell of "Oppenheimer" Initiated at Buy and Held Target at $199 on, Friday, March 20th, 2020